Channel Medsystems
Matt Vitale started their work experience in 1999 as a Sales Representative at Timm Medical Technologies. Matt then worked as a Sales Representative at American Medical Systems, LLC from 2001 to 2005. From 2005 to 2010, they served as a Regional Business Manager at Novasys Medical. Matt then joined Bayer as a Regional Business Director from 2010 to 2014. Following that, Matt worked as the Vice President of Sales at BionX Medical Technologies, where they were responsible for rebuilding the sales and clinical team and establishing the market for advanced bionic prosthetics. From 2018 to 2021, they served as a Commercial Business Development Manager at Boston Scientific. In 2021, Matt joined Olympus Corporation of the Americas as the Executive Director of Market Development - Olympus Urology. Currently, they are working as the East Coast Area Sales Director at Channel Medsystems.
Matt Vitale attended Arkansas Tech University, where they pursued a Bachelor of Science degree in Business Administration. However, no specific information regarding the start and end years of their education at this institution is provided.
This person is not in any offices
Channel Medsystems
Channel Medsystems is a medical device company dedicated to empowering every woman to take control of her health journey and live her best life. With a commitment to deliver innovative technologies that exceed the expectations of women and their gynecologists, Channel strives to develop easy-to-use, safe, and cost-effective medical devices, resulting in exceptional outcomes and superior patient comfort that are accessible to all women. Led by chief executive officer Ric Cote, Channel Medsystems has a seasoned executive leadership team with a track record of commercializing innovative medical devices. The company’s technology, Cerene® Cryotherapy, is a well-tolerated in-office endometrial ablation treatment that safely and effectively reduces heavy menstrual bleeding without general anesthesia and while preserving access to the uterine cavity for future diagnostic evaluations. Please review safety info (https://bit.ly/3qgfAtS) for additional information.